Evalution of circulating fibroblast growth factor 21 in Type 2 diabetic patients with nephropathy
Sahar Mohamed Farag El-Sayed;
Abstract
Microalbuminuria is often cited as a sensitive early marker for diabetic kidney disease and is thought to precede the more detrimental events seen in advanced stages of diabetic nephropathy.
Aim: The aim of this study was to evaluate the levels of Fibroblast growth factor 21, a modulator of cellular activities, in the different stages of diabetic albuminuria in an attempt to examine the possibility of considering FGF21 as a predictor marker of diabetic nephropathy in Type 2 diabetic patients whom at risk of that disease.
Aim: The aim of this study was to evaluate the levels of Fibroblast growth factor 21, a modulator of cellular activities, in the different stages of diabetic albuminuria in an attempt to examine the possibility of considering FGF21 as a predictor marker of diabetic nephropathy in Type 2 diabetic patients whom at risk of that disease.
Other data
| Title | Evalution of circulating fibroblast growth factor 21 in Type 2 diabetic patients with nephropathy | Other Titles | تقييم عامل نمو الخلايا الليفيه 21 في مرضي السكرى من النوع الثاني المصاحب بالإعتلال الكلوى | Authors | Sahar Mohamed Farag El-Sayed | Issue Date | 2019 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.